MetaCap

Who Owns IRulya Therapeutics Stock?

NASDAQ: IRLAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

39.88-0.06 (-0.15%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
12.11%
Institutional holders
37
  • Institutions 12.1%
  • Insiders 1.0%
  • Public and other 86.9%

Who owns IRulya Therapeutics stock?

Institutional investors own about 12.1% of IRulya Therapeutics's shares, spread across 37 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 1.01% of IRLA.

The largest institutional holders are Janus Henderson Group Ltd. (15.82%), Ikarian Capital, LLC (0.88%) and Squadron Capital Management LLC (0.83%). Together, the top 10 institutions control 20.2% of shares outstanding. In their latest filings, 9 of the top 10 institutions increased their IRLA positions and 0 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of IRLA

IRulya Therapeutics top institutional holders
InstitutionShares% HeldChange
Janus Henderson Group Ltd.1.71M15.82%+100.0%
Ikarian Capital, LLC95.65K0.88%+32.4%
Squadron Capital Management LLC90.00K0.83%+122.9%
Millennium Management Llc72.25K0.67%+2.1%
Balyasny Asset Management LP69.97K0.65%0.0%
Acuta Capital Partners LLC52.92K0.49%+100.0%
Birchview Capital, LP40.60K0.37%+100.0%
Boothbay Fund Management, LLC21.29K0.20%+53.0%
Jane Street Group, LLC20.16K0.19%+59.4%
Seven Fleet Capital Management LP11.99K0.11%+100.0%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of IRLA

IRulya Therapeutics top fund holders
FundShares% Held
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund12.04K0.11%
Fidelity Concord Street Trust-Fidelity Extended Market Index Fund5.34K0.05%
Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund1.25K0.01%
Fidelity Concord Street Trust-Fidelity Total Market Index Fund1.15K0.01%
Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund5800.01%
Guggenheim Active Allocation Fund10.00%

Frequently asked questions

Who is the largest shareholder of IRulya Therapeutics?

Janus Henderson Group Ltd. is the largest institutional shareholder of IRLA, owning 15.82% of shares outstanding (1.71M shares) as of its latest 13F filing.

What percentage of IRulya Therapeutics is owned by institutions?

Institutions own about 12.1% of IRLA shares and 12.2% of the public float.

How much of IRulya Therapeutics do insiders own?

Insiders, such as officers and directors, own about 1.01% of IRLA shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related